Researchers have created a virtual reality (VR) headset that could be used by doctors to conduct medical assessments with patients who live in rural areas, have infectious diseases, or have mental health issues that could lead them to act violently toward others.
Compared to conventional video or phone consultations, the new technology will give patients a more involved and engaging experience. It can result in an immersive environment where patients can feel like they are physically present with their healthcare provider despite being at a distance. This may improve the flow of information between patients and physicians.
VR can be combined with wearable technology and sensors to remotely monitor patients' health and collect information for accurate diagnosis and customized treatments. VR is also used for therapies in mental health, including phobia exposure therapy and post-traumatic stress disorder . It can be used to induce relaxation, which can be of great help for people experiencing emotional distress.
"We used a facial capture device and trained a neural network to identify various key emotions. These emotions were then relayed to the clinician, to help in managing the diagnosis session. I really enjoyed the journey of developing the neural network and applying the trained modules to this real-life scenario."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CERN researchers continue to look for elusive monopolesMagnetic monopoles are consistent with quantum mechanics and are called 'as one of the safest bets that one can make about physics not yet seen.”
Read more »
In major breakthrough, researchers close in on potential preeclampsia cureResearchers have achieved a significant breakthrough in identifying the primary cause and potential treatment for preeclampsia, a severe pregnancy complication. Experts pinpointed a toxic protein named cis P-tau in the blood and placenta of individuals with preeclampsia. The study describes cis P-tau as a pivotal circulating instigator of preeclampsia. An antibody developed in 2012 to target only the toxic protein while leaving its healthy counterpart unscathed is currently undergoing clinical trials in human patients suffering from traumatic brain injury and Alzheimer's Disease. The antibody has shown promising results in animal models and human cell cultures in treating the brain conditions. Upon testing this antibody in mice, the researchers found the all symptoms associated with preeclampsia were corrected.
Read more »
Researchers uncover unconventional charge carriers in a triangular-lattice Mott insulatorMott insulators are a peculiar class of materials with structures that should theoretically conduct electricity, but that are instead insulators. These materials contain strongly correlated electrons, which can generate highly entangled many-body states marked by unconventional excitations.
Read more »
Researchers propose novel paradigm of metal electron-shuttle catalysisProfessor Huang Hanmin's research team from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) proposed a new paradigm of metal electron-shuttle catalysis, which has been pioneeringly employed to achieve alkylative aminomethylation of unactivated alkene for the first time. Their work was published in Nature Catalysis on August 21.
Read more »
Researchers illuminate 'Snowball Earth' melting and early life evolutionA research team led by Prof. Shen Yan'an from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) conducted a systematic study of the interglacial stratigraphy in South China by means of high-precision sulfur and mercury isotope analyses.
Read more »
Researchers study the formation of cardenolides in plantsScientists at the Max Planck Institute for Chemical Ecology in Jena are investigating the previously largely unknown biosynthetic pathway that leads to the formation of cardenolides in plants.
Read more »